BPC-157 (2mg)
BPC-157 (Body Protection Compound-157) is a synthetic 15-amino acid peptide derived from a gastric protein sequence, studied for its tissue healing and cytoprotective properties. This 2 mg vial is ideal for short cycles or trial use.
Reviewed by the AllPeptides.eu Editorial Team·Last reviewed: 2026-06-16
Educational information. Not medical advice, and no efficacy claim is implied. Regulatory approval is not a use recommendation by AllPeptides.eu.
⚠️ For informational/educational purposes only. Not medical advice. We do not sell any products. Self-treatment carries serious risks — consult a healthcare professional. Disclaimer
Research monograph
See the full BPC-157 encyclopedia page with mechanism, evidence tier, related variants and research context.
How It Works
BPC-157 regulates nitric oxide pathways and growth factor expression to promote angiogenesis and collagen deposition in damaged tissues. Animal models report accelerated healing of gut, tendon, ligament, and muscle injuries.
Quick Start
- Reconstitution: Add 1.0 mL bacteriostatic water → 2.0 mg/mL concentration.
- Typical Daily Range: 200–500 mcg once daily (gradual titration).
- Storage: Lyophilized: freeze at −20 °C; post-reconstitution, refrigerate at 2–8 °C.
Typical Approach (1 mL = 2.0 mg/mL)
Route: Subcutaneously | Frequency: Once daily
| Week | Dose | Units (per injection) |
|---|---|---|
| Weeks 1–2 | 200 mcg (0.2 mg) | 10 Units (0.10 mL) |
| Weeks 3–4 | 300 mcg (0.3 mg) | 15 Units (0.15 mL) |
| Weeks 5–8 | 500 mcg (0.5 mg) | 25 Units (0.25 mL) |
Studies report administration once daily subcutaneously. The 2 mg vial covers ~4–10 days depending on the dose.
Related compounds
Reconstitution Steps
- Withdraw 1.0 mL bacteriostatic water with a sterile syringe.
- Inject slowly down the side of the vial; avoid frothing.
- Gently swirl until fully dissolved.
- Date the vial and refrigerate at 2–8 °C.
Protocol Overview
- Goal: Support tissue healing based on preclinical evidence.
- Schedule: Daily subcutaneous injections for 4–8 weeks.
Dosing Protocol
- Initiation: 200 mcg daily; increase by 100 mcg every 2 weeks.
- Target: 300–500 mcg daily by Weeks 3–8.
- Frequency: Once daily (subcutaneous).
- Cycle Duration: 4–8 weeks.
- Break between cycles: After the cycle, a 2–4 week washout period is recommended before repeating.
Washout & Cycle Restart
When can I restart?
After the cycle, a 2–4 week washout period is recommended before repeating.
Minimum wait period: 2 weeks
Storage Instructions
- Lyophilized: Store at −20 °C in dry, dark conditions.
- Reconstituted: Refrigerate at 2–8 °C; use within 14 days.
- Allow vials to reach room temperature before opening.
Important Notes
- The 2 mg vial is ideal for trial or short cycles.
- Human data on BPC-157 is preliminary.
Potential Benefits & Side Effects
Potential Benefits:
- Supports tissue repair in multiple injury models (animal data).
- Anti-inflammatory and cytoprotective properties.
- Well-tolerated with no severe adverse events (Phase I).
- Low injection volume (1 mL reconstitution).
Potential Side Effects:
- Injection site reactions: redness, swelling, stinging (15–25%).
- Transient nausea (5–10%, primarily the first week).
- Dizziness (3–7%, rare).
- Human clinical data is very limited.
⚠️ Serious Warnings & Long-Term Risks
The following warnings are based on published literature, FDA labels, and post-marketing surveillance. They do not constitute medical advice. Consult a healthcare professional.
Theoretical concern: angiogenesis & oncogenesis
BPC-157 promotes angiogenesis (VEGF upregulation). May theoretically enhance blood supply to existing tumors. No clinical data in humans.
📄 J Physiol Pharmacol 2010References
- Journal of Pharmacological Sciences — BPC-157 promotes healing via NO-system regulation
View Source - Pharmaceuticals (MDPI) — Multifunctionality of BPC-157 (2025)
View Source - Current Pharmaceutical Design (PMC) — BPC-157 stable gastric pentadecapeptide
View Source
Recommended Supplements
Curcumin (Turmeric Extract)
Collagen Peptides
External Sources & Regulatory Status
Regulatory Approvals
Research-only — No regulatory approval (extensive preclinical research)
Educational information. Not medical advice, and no efficacy claim is implied. Regulatory approval is not a use recommendation by AllPeptides.eu.
Continue Your Research
Explore tools and guides related to this protocol.
Important Disclaimer
The content of this website is provided exclusively for informational and educational purposes within the context of research literature.
Read the full Disclaimer →